Head-to-head · Value Score
CoreAge Rx vs Longevixx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Longevixx a 69. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLongevixx
#254 · Grade C · Watch List
Est. first month
$199/mo month-to-month, charged every 30 days ($149 is the first month only)
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 69 — an est. $99/mo first month, with no teaser step-up baked in. Longevixx isn't out of it: Shoppers who want a low-dose or daily oral option alongside the standard doses, and who will budget from the renewal price rather than the ticker.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Longevixx |
|---|---|---|
| Value Score | 93 (A+) | 69 (C) |
| Est. first month | $99/mo | $199/mo month-to-month, charged every 30 days ($149 is the first month only) |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $99/mo | $199/mo month-to-month, charged every 30 days ($149 is the first month only) |
| Tirzepatide | $149/mo | $299/mo month-to-month, charged every 30 days |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states claimed, no list published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Longevixx
Semaglutide at $199 a month with tirzepatide at $299, advertised from $149 — a figure the checkout itself labels a first-month discount, sitting directly beneath a promise that the price never changes.
Why it's a deal
- The full ladder is visible at the checkout before payment, including the two programs the marketing hides: $199 and $299 standing, $129 for the low-dose injectable and $229 for the daily oral
- The billing cadence is stated exactly rather than implied — charged every thirty days — and an electronic notice is sent five to seven days before each transaction, which is the warning most subscriptions do not give
- Cancellation is one action in the account: turn off auto-refill up to forty-eight hours before the processing date, stated once and in the terms rather than in marketing copy
- A real legal entity, a street address and a phone number are published, and clinical hours are stated rather than implied
- Nineteen peptide programs are priced publicly on the same site, so the company demonstrably can publish a price list and does
The fine print
- The advertised price is an introductory price. Every public surface says "from $149/mo" and the checkout labels that exact figure "$50 off first month" against a standing $199 — a $600-a-year gap between the number that recruits and the number that bills
- The line "same price, all dosages, no hidden fees, everything included" is printed directly above a card whose price rises after month one
- The low-dose and daily oral programs never name the molecule they contain, on any surface, and the oral program has no public page at all — it exists only behind a collapsed control in the checkout
- No compounding pharmacy, no medical group and no clinician is named anywhere, and neither 503A nor 503B appears on the domain at all
- Coverage is claimed as fifty states on the marketing pages, described as "the states where it is licensed" on the contact page and "the states where we're available" in the treatment questions, with no list anywhere
- Patient counts and ratings disagree across the site — two different patient totals and three different average ratings — and no review platform is named for any of them
- The checkout promises access to the care team around the clock while the published clinical hours are weekdays only
- A promise that nothing is charged if a patient is not approved appears on the homepage with no matching clause anywhere in the terms
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Longevixx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.